Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Lack of B-cell Depletion with Ocrelizumab

Author:Saldivar, Sergio   Freedman, Mark   Rush, Carolina   Brooks, John   

Session Name:P7: MS Therapeutics 1  

Topic:MS and Inflammatory Disease  

Program Number:P7.006  

Author Institution:The Ottawa Hospital Research Institute, Ottawa, ON, Canada  

Stroke Hospitalization Administration & Monitoring: Routine Or Covid-19 Care (SHAMROCC)

Author:Langlois-Therien, Timothe   Shamy, Michel   Dewar, Brian   Lun, Ronda   Dowlatshahi, Dariush   Blacquiere, Dylan   Stotts, Grant   Fahed, Robert   Ducroux, Célina   

Session Name:P7: Cerebrovascular Disease and Interventional Neurology: Thrombolytic Therapy and Acute Stroke Treatments  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P7.006  

Author Institution:Ottawa Hospital - Civic Campus, Ottawa, ON, Canada  Ottawa Hospital Research Institute, Ottawa, ON, Canada  

Assessment of altered mental status in the Emergency Department using quantitative pupillometry: a prospective cohort study

Author:Alexis, Maya   Fernández-Penny, Felix   Abella, Benjamin   

Session Name:P7: General Neurology: Clinical Practice 2  

Topic:General Neurology  

Program Number:P7.006  

Author Institution:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA  University of Pennsylvania, Philadelphia , PA  University of Pennsylvania, Philadelphia, PA  

Long-term Safety of Ozanimod in Relapsing Multiple Sclerosis and Moderately to Severely Active Ulcerative Colitis

Author:Cree, Bruce A. C.   Danese, Silvio   Wolf, Douglas C.   Alekseeva, Olga   Charles, Lorna   Petersen, AnnKatrin   Sheffield, James K.   Cheng, Chun-Yen   Riolo, Jon V.   Silva, Diego   Lublin, Fred D.   Rubin, David T.   Cohen, Jeffrey A.   

Session Name:P7: MS Therapeutics 1  

Topic:MS and Inflammatory Disease  

Program Number:P7.007  

Author Institution:Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, San Francisco, CA  Humanitas University, Milan, Italy, Milan, Italy  Atlanta Gastroenterology Associates, LLC, Atlanta, Georgia, Atlanta, GA  Nizhegorodskaya Regional Clinical, Nizhegorodskaya oblast' Russia, Nizhegorodskaya oblast' , Russian Federation  Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ  Mount Sinai Medical Center, New York, New York, New York, NY  University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, Chicago, IL  Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH  

Identifying Digital Biomarkers for the Self-Monitoring of Patients Living with Generalized Myasthenia gravis: a Proof of Concept

Author:Laforet, Pascal   Orlikowski, David   Nicolas, Guillaume   Prigent, Hélène   Berling, Edouard   N'Dah-Sekou, Ghislain   Gorin, Clarissa   Moreira, Ana Júlia   Narcy, Juliette   Plaud, Angéline   Touré Cuq, Emma   Keller, Martin   Werneburg, Brian   Aras, Emrah   Benatar, Michael   

Session Name:P7: Neuromuscular Disease: Neuromuscular Junction Disorders 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P7.007  

Author Institution:Nord-Est/Ile-de-France Neuromuscular Reference Center, UMR 1179, Neurology Department, Raymond-Poincaré Hospital, Garches, and FHU PHENIX, France, Paris, France  Nord-Est/Ile-de-France Neuromuscular Reference Center, UMR 1179, CIC 1429, Neurology Department, Raymond-Poincaré Hospital, Garches and FHU PHENIX,UVSQ Paris-Saclay University, France, Paris, France  Ad Scientiam, Paris, France, Paris, France  Alexion Pharma GmbH, Giesshübelstrasse 30, 8045 Zürich, Switzerland, Zürich, Switzerland  Alexion Pharmaceuticals Inc., 121 Seaport Blvd, Boston, MA 02025, USA, Boston, MA  Department of Neurology, Emory University, GA, USA, Atlanta, GA